Latest news from The Cancer Research Institute (CRI) and The Mark Foundation for Cancer Research on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/cancer-research-institute-and-the-mark-foundation-for-cancer-research-launch-collaboration-to-evaluate-liquid-biopsy-for-more-accurate-and-rapid-assessment-of-lung-cancer-patient-response-to-immunotherapy/?sc=rsin /articles/cancer-research-institute-and-the-mark-foundation-for-cancer-research-launch-collaboration-to-evaluate-liquid-biopsy-for-more-accurate-and-rapid-assessment-of-lung-cancer-patient-response-to-immunotherapy/?sc=rsin Wed, 29 Jul 2020 08:55:30 EST The Cancer Research Institute (CRI) and The Mark Foundation for Cancer Research have launched a clinical trial that aims to demonstrate the utility of a novel, ultra-sensitive biomarker-directed blood test, or liquid biopsy, in assessing cancer patient responses to immunotherapy. The Cancer Research Institute (CRI) and The Mark Foundation for Cancer Research